학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 1,451건 | 목록
1~20
Academic Journal
Korakis, I.; Ouali, K.; Hanvic, B.; Verlingue, L.; Allignet, B.; Lusque, A.; Clementei, S.; Magne, E.; Massard, C.; Delord, J.-P.; Cassier, P.; Baldini, C.; Segier, B.; Gomez-Roca, C.
ESMO Open. 10(8)
Academic Journal
Westphalen, C.B. ; Boscolo Bielo, L. ; Aftimos, P. ; Beltran, H. ; Benary, M. ; Chakravarty, D. ; Collienne, M. ; Dienstmann, R. ; El Helali, A. ; Gainor, J. ; Horak, P. ; Le Tourneau, C. ; Marchiò, C. ; Massard, C. ; Meric-Bernstam, F. ; Pauli, C. ; Pruneri, G. ; Roitberg, F. ; Russnes, H.E.G. ; Solit, D.B. ; Starling, N. ; Subbiah, V. ; Tamborero, D. ; Tarazona, N. ; Turnbull, C. ; van de Haar, J. ; André, F. ; Mateo, J. ; Curigliano, G.
In Annals of Oncology June 2025 36(6):614-625
155TiP Exploring mechanisms of action and resistance to innovative therapeutic drugs: UNLOCK program
Academic Journal
Rodriguez, J.E.; Alonso de Castro, B.; Mosele, M.F.; Nicotra, C.; Camus, M. Ngo; Halimi, A.; Natali, E.; Scoazec, J-Y.; Vasseur, D.; Bigot, L.; Nikolaev, S.; Wang, J.; Gerome, J-C.; Aix, S. Ponce; Massard, C.; André, F.; Italiano, A.; Friboulet, L.; Loriot, Y.
ESMO Open. 9
Academic Journal
Charton, E. ; Baldini, C. ; Fayet, Y. ; Schultz, E. ; Auroy, L. ; Vallier, E. ; Italiano, A. ; Robert, M. ; Coquan, E. ; Isambert, N. ; Moreau, P. ; Touzeau, C. ; Le Tourneau, C. ; Ghrieb, Z. ; Kiladjian, J.-J. ; Delord, J.-P. ; Gomez Roca, C. ; Vey, N. ; Barlesi, F. ; Lesimple, T. ; Penel, N. ; Soria, J.-C. ; Massard, C. ; Besle, S.
In ESMO Open August 2023 8(4)
Academic Journal
Bernard-Tessier A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Department of Oncology, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif 94800, France.; Naoun N; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Barraud S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Flippot R; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.; Pobel C; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Rey M; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Baldini C; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.; Massard C; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.; Patrikidou A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.; Fuerea A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Di Palma M; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Albigès L; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.; Loriot Y; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Paris-Saclay University, Kremlin-Bicetre, France.; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.; Fizazi K; Department of Cancer Medicine, Gustave Roussy, Villejuif, France, Paris-Saclay University, Kremlin-Bicetre, France.
Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Academic Journal
Simonelli, M. ; Garralda, E. ; Eskens, F. ; Gil-Martin, M. ; Yen, C.-J. ; Obermannova, R. ; Chao, Y. ; Lonardi, S. ; Melichar, B. ; Moreno, V. ; Yu, M.-L. ; Bongiovanni, A. ; Calvo, E. ; Rottey, S. ; Machiels, J.-P. ; Gonzalez-Martin, A. ; Paz-Ares, L. ; Chang, C.-L. ; Mason, W. ; Lin, C.-C. ; Reardon, D.A. ; Vieito, M. ; Santoro, A. ; Meng, R. ; Abbadessa, G. ; Menas, F. ; Lee, H. ; Liu, Q. ; Combeau, C. ; Ternes, N. ; Ziti-Ljajic, S. ; Massard, C.
In ESMO Open October 2022 7(5)
Academic Journal
Chen J; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Levy A; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Tian AL; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Huang X; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Cai G; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Fidelle M; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France; CICBT1428, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Rauber C; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France; Department of Gastroenterology and Infectious Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Ly P; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Pizzato E; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Sitterle L; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Piccinno G; Department of Computational, Cellular and Integrative Biology, University of Trento, 38123 Trento, Italy.; Liu P; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France.; Durand S; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France.; Mao M; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France; General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China; Zhejiang University, Hangzhou, Zhejiang 310000, China.; Zhao L; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France.; Iebba V; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France.; Felchle H; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France; Technical University of Munich (TUM), TUM School of Medicine and Health, Klinikum rechts der Isar, Department of Radiation Oncology, 81675 Munich, Germany.; Mallard de La Varende AL; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Fischer JC; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France; Technical University of Munich (TUM), TUM School of Medicine and Health, Klinikum rechts der Isar, Department of Radiation Oncology, 81675 Munich, Germany.; Thomas S; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Greten TF; Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Jones JC; Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Monge C; Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA.; Formenti S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA.; Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, 37134 Verona, Italy.; Dionisi V; Department of Radiation Oncology, University of Verona Hospital Trust, 37126 Verona, Italy.; Massard C; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, 94805 Villejuif, France.; Blanchard P; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Robert C; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Quevrin C; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Lopes E; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Clémenson C; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Mondini M; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Meziani L; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Zhan Y; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Zeng C; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Cai Q; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Morel D; Department of Radiation Oncology, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Sun R; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Laurent PA; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Mangoni M; Radiotherapy Unit, Department of Experimental and Clinical Biomedical Sciences'Mario Serio' University of Florence, 50134 Florence, Italy.; Di Cataldo V; Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, 50134 Florence, Italy.; Arilli C; Medical Physics Unit, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.; Trommer M; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Department of Radiation Oncology, Heidelberg VIC 3084, Melbourne, Australia.; Wegen S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Neppl S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany.; Riechelmann RP; Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo 01509-900, Brazil.; Camandaroba MP; Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo 01509-900, Brazil.; Neto ES; Department of Radiation Oncology, AC Camargo Cancer Center, São Paulo 01509-001, Brazil.; Fournier PE; IHU Méditerranée Infection, 13005 Marseille, France.; Segata N; Department of Computational, Cellular and Integrative Biology, University of Trento, 38123 Trento, Italy; IEO, Istituto Europeo di Oncologia IRCCS, 20139 Milan, Italy.; Holicek P; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Sotio Biotech, 19000 Prague, Czech Republic.; Galluzzi L; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA.; Buqué A; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA.; Alves Costa Silva C; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France.; Derosa L; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France; CICBT1428, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.; Kroemer G; Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Cancer Campus, 94805 Villejuif, France; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, 75006 Paris, France; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France.; Chen C; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China. Electronic address: czchen2@stu.edu.cn.; Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif Cedex, France; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94805 Villejuif, France; CICBT1428, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France. Electronic address: Laurence.zitvogel@gustaveroussy.fr.; Deutsch E; Faculté de Médecine, Université Paris-Saclay, 94270 Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France; INSERM U1030, Radiothérapie Moléculaire et Innovations Thérapeutiques, Gustave Roussy Cancer Campus (GRCC), 94805 Villejuif, France.
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
Delaye, M.; Lawrance, L.; Belkouchi, Y.; Decazes, P.; Wirth, F.; Bône, A.; Ouali, K.; Hollebecque, A.; Smolenschi, C.; Champiat, S.; Danlos, F-X.; Beshiri, K.; Sakkal, M.; Massard, C.; Vera, P.; Marabelle, A.; Aix, S. Ponce; Lassau, N.; Ammari, S.; Baldini, C.
ESMO Open. 9
Academic Journal
Loriot, Y. ; Marabelle, A. ; Guégan, J.P. ; Danlos, F.X. ; Besse, B. ; Chaput, N. ; Massard, C. ; Planchard, D. ; Robert, C. ; Even, C. ; Khettab, M. ; Tselikas, L. ; Friboulet, L. ; André, F. ; Nafia, I. ; Le Loarer, F. ; Soria, J.C. ; Bessede, A. ; Italiano, A.
In Annals of Oncology November 2021 32(11):1381-1390
Academic Journal
Baldini, C. ; Charton, E. ; Schultz, E. ; Auroy, L. ; Italiano, A. ; Robert, M. ; Coquan, E. ; Isambert, N. ; Moreau, P. ; Le Gouill, S. ; Le Tourneau, C. ; Ghrieb, Z. ; Kiladjian, J.J. ; Delord, J.P. ; Roca, C. Gomez ; Vey, N. ; Barlesi, F. ; Lesimple, T. ; Penel, N. ; Soria, J.C. ; Massard, C. ; Besle, S.
In ESMO Open June 2022 7(3)
Conference
2012 IEEE International Geoscience and Remote Sensing Symposium Geoscience and Remote Sensing Symposium (IGARSS), 2012 IEEE International. :1668-1671 Jul, 2012
Academic Journal
Levy A; Department of Radiation Oncology, Gustave Roussy, Villejuif, France. antonin.levy@gustaveroussy.fr.; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France. antonin.levy@gustaveroussy.fr.; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France. antonin.levy@gustaveroussy.fr.; Sarcoma unit, Gustave Roussy, Villejuif, France. antonin.levy@gustaveroussy.fr.; Morel D; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Texier M; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France.; Oncostat 1018 Inserm, University Paris-Saclay, Villejuif, France.; Rodriguez-Ruiz ME; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Bouarroudj L; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Bioinformatic platform, Gustave Roussy, Villejuif, France.; Bouquet F; Product Development Medical Affairs, F Hoffmann-La Roche Ltd, Basel, Switzerland.; Bustillos A; Product Development Medical Affairs, F Hoffmann-La Roche Ltd, Basel, Switzerland.; Quevrin C; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Clémenson C; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Mondini M; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Meziani L; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Sun R; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Zaghdoud N; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France.; Tselikas L; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Department of Interventional Radiology, Gustave Roussy, Villejuif, France.; Assi T; Sarcoma unit, Gustave Roussy, Villejuif, France.; Faron M; Sarcoma unit, Gustave Roussy, Villejuif, France.; Oncostat 1018 Inserm, University Paris-Saclay, Villejuif, France.; Honoré C; Sarcoma unit, Gustave Roussy, Villejuif, France.; Ngo C; Sarcoma unit, Gustave Roussy, Villejuif, France.; Verret B; Sarcoma unit, Gustave Roussy, Villejuif, France.; Le Péchoux C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Sarcoma unit, Gustave Roussy, Villejuif, France.; Le Cesne A; Sarcoma unit, Gustave Roussy, Villejuif, France.; Ginhoux F; Gustave Roussy, Inserm U1015, Université Paris-Saclay, Villejuif, France.; Massard C; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France.; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.; Bahleda R; Sarcoma unit, Gustave Roussy, Villejuif, France.; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.; Deutsch E; Department of Radiation Oncology, Gustave Roussy, Villejuif, France. eric.deutsch@gustaveroussy.fr.; Gustave Roussy, Inserm U1030, Université Paris-Saclay, Villejuif, France. eric.deutsch@gustaveroussy.fr.; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France. eric.deutsch@gustaveroussy.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Academic Journal
Jardali G; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France. Electronic address: ghina.jardali@gustaveroussy.fr.; Lawrance L; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France; Guerbet Research, 93420 Villepinte, France.; Dawi L; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Dupont J; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Gautier O; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Kind M; Department of Medical Imaging, Institut Bergonié, 33076 Bordeaux, France.; Ammari S; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Hadchiti J; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France.; Choucair A; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Bayle A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France.; Cournède PH; MICS Lab, CentraleSupelec, Université Paris-Saclay, 91192 Gif-Sur-Yvette, France; IHU PRISM National Precision Medicine Center in Oncology, Gustave Roussy, 94800 Villejuif, France.; Borget I; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France; Department of Epidemiology and Biostatistics, Gustave Roussy and University Paris Saclay, 94805 Villejuif, France.; Muller S; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Bidault F; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France.; Balleyguier C; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.; Hollebecque A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Department of Cancer Medicine, Gustave Roussy - Cancer Campus, 94805 Villejuif, France.; Loriot Y; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France.; Dall-Olio FG; Department of Cancer Medicine, Gustave Roussy - Cancer Campus, 94805 Villejuif, France.; Besse B; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France; Department of Cancer Medicine, Gustave Roussy - Cancer Campus, 94805 Villejuif, France.; Lacroix L; Medical Biology and Pathology Department and AMMICa platform UAR3655/US23, Gustave Roussy Cancer Campus, 94805 Villejuif, France.; Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy - Cancer Campus, 94805 Villejuif, France.; Bône A; Guerbet Research, 93420 Villepinte, France.; André F; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France; Department of Cancer Medicine, Gustave Roussy - Cancer Campus, 94805 Villejuif, France; IHU PRISM National Precision Medicine Center in Oncology, Gustave Roussy, 94800 Villejuif, France.; Massard C; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France.; Barlesi F; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France; Department of Cancer Medicine, Gustave Roussy - Cancer Campus, 94805 Villejuif, France.; Italiano A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Center, 33076 Bordeaux, France; Faculté de Médecine, Université de Bordeaux, 33076 Bordeaux, France; IHU PRISM National Precision Medicine Center in Oncology, Gustave Roussy, 94800 Villejuif, France.; Lassau N; Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France; IHU PRISM National Precision Medicine Center in Oncology, Gustave Roussy, 94800 Villejuif, France.
Publisher: Elsevier Masson Country of Publication: France NLM ID: 101568499 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5684 (Electronic) Linking ISSN: 22115684 NLM ISO Abbreviation: Diagn Interv Imaging Subsets: MEDLINE
Academic Journal
Smolenschi C; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France. cristina.smolenschi@gustaveroussy.fr.; Medical Oncology Department, Gastro Intestinal Oncology, Gustave Roussy, Villejuif, France. cristina.smolenschi@gustaveroussy.fr.; Sisoudiya SD; Foundation Medicine Inc., Boston, MA, USA.; Hollebecque A; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Sivakumar S; Foundation Medicine Inc., Boston, MA, USA.; Montesion M; Foundation Medicine Inc., Boston, MA, USA.; Euzen V; Virology Department, AP-HP, Hôpital Saint Louis, Paris, France.; Boige V; Medical Oncology Department, Gastro Intestinal Oncology, Gustave Roussy, Villejuif, France.; Boilève A; Medical Oncology Department, Gastro Intestinal Oncology, Gustave Roussy, Villejuif, France.; Valery M; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Sourouille I; Department of Surgical Oncology, Gustave Roussy, Villejuif, France.; Bayle A; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Aldea M; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Rodriguez JE; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Gelli M; Department of Surgical Oncology, Gustave Roussy, Villejuif, France.; Dall'Olio FG; Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France.; Tarabay A; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Pudlarz T; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Bahleda R; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Fuerea A; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Benhaim L; Department of Surgical Oncology, Gustave Roussy, Villejuif, France.; de Sevilla EF; Department of Surgical Oncology, Gustave Roussy, Villejuif, France.; Bani M; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; Dartigues P; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; Pernot S; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Boillet G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Beshiri K; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Massard C; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Friboulet L; Paris-Saclay University, Gustave Roussy, Villejuif, France.; Facchinetti F; Paris-Saclay University, Gustave Roussy, Villejuif, France.; Lacroix L; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France.; Rouleau E; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; Barlesi F; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Ducreux M; Medical Oncology Department, Gastro Intestinal Oncology, Gustave Roussy, Villejuif, France.; Italiano A; Drug Development Department (DITEP) Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Sharaf R; Foundation Medicine Inc., Boston, MA, USA.; Vasseur D; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France. damien.vasseur@gustaveroussy.fr.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France. damien.vasseur@gustaveroussy.fr.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Loriot Y; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; PRISM, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France. maud.kamal@gustaveroussy.fr.; Syx L; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Nicolle R; Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-, 75018, Paris, France.; Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Menssouri N; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Duquesne I; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Lavaud P; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Nicotra C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Ngocamus M; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Lacroix L; Biopath department, Gustave Roussy, Villejuif, France.; Tselikas L; Department of interventional radiology, Gustave Roussy, Villejuif, France.; Crehange G; Department of Radiothérapie, Institut Curie, 75005 Paris & 92210 Saint-Cloud, Paris, France.; Friboulet L; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France.; Castel-Ajgal Z; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Neuzillet Y; Department of Urology, Foch Hospital, Suresnes, France.; Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Beuzeboc P; Department of Urology, Foch Hospital, Suresnes, France.; Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Gutman T; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Wong J; Department of Genetics, Institut Curie, 75005, Paris, France.; Radvanyi F; UMR144, Institut Curie, 75005, Paris, France.; Dureau S; Biometry unit, direction of clinical research, Institut Curie, 75005, Paris, France.; Scoazec JY; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Biopath department, Gustave Roussy, Villejuif, France.; Servant N; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Allory Y; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.; Besse B; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Andre F; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Massard C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Bieche I; Department of Genetics, Institut Curie, 75005, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Loriot Y; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; PRISM, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France. maud.kamal@gustaveroussy.fr.; Syx L; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Nicolle R; Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-, 75018, Paris, France.; Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Menssouri N; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Duquesne I; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Lavaud P; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Nicotra C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Ngocamus M; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Lacroix L; Biopath department, Gustave Roussy, Villejuif, France.; Tselikas L; Department of interventional radiology, Gustave Roussy, Villejuif, France.; Crehange G; Department of Radiothérapie, Institut Curie, 75005 Paris & 92210 Saint-Cloud, Paris, France.; Friboulet L; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France.; Castel-Ajgal Z; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Neuzillet Y; Department of Urology, Foch Hospital, Suresnes, France.; Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Beuzeboc P; Department of Urology, Foch Hospital, Suresnes, France.; Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Gutman T; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Wong J; Department of Genetics, Institut Curie, 75005, Paris, France.; Radvanyi F; UMR144, Institut Curie, 75005, Paris, France.; Dureau S; Biometry unit, direction of clinical research, Institut Curie, 75005, Paris, France.; Scoazec JY; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Biopath department, Gustave Roussy, Villejuif, France.; Servant N; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Allory Y; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.; Besse B; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Andre F; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.; Massard C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France.; Bieche I; Department of Genetics, Institut Curie, 75005, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Hollebecque, A. ; Bahleda, R. ; Faivre, L. ; Adam, J. ; Poinsignon, V. ; Paci, A. ; Gomez-Roca, C. ; Thery, J.C. ; Le Deley, M.C. ; Varga, A. ; Gazzah, A. ; Ileana, E. ; Gharib, M. ; Angevin, E. ; Malekzadeh, K. ; Massard, C. ; Soria, J.C. ; Spano, J.P.
In European Journal of Cancer August 2017 81:81-89
Academic Journal
Brazilian Journal of Biology, Iss 0 (2018)
Brazilian Journal of Biology v.79 n.4 2019
Brazilian Journal of Biology
Instituto Internacional de Ecologia (IIE)
instacron:IIE
Brazilian Journal of Biology, Volume: 79, Issue: 4, Pages: 686-696, Published: 29 OCT 2018
Brazilian Journal of Biology, Issue: ahead, Published: 29 OCT 2018
Brazilian Journal of Biology v.79 n.4 2019
Brazilian Journal of Biology
Instituto Internacional de Ecologia (IIE)
instacron:IIE
Brazilian Journal of Biology, Volume: 79, Issue: 4, Pages: 686-696, Published: 29 OCT 2018
Brazilian Journal of Biology, Issue: ahead, Published: 29 OCT 2018
Academic Journal
Vaz Ferreira A; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Department of Medical Oncology, Hospital Espirito Santo, Évora, Portugal.; Delaye M; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France. matthieu.delaye@gustaveroussy.fr.; Pages A; Gustave Roussy. Biostatistics and Epidemiology Department, Oncostat Team, CESP U1018, Inserm, Paris-Saclay University, Orsay, France.; Hollebecque A; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Paris-Saclay University, Orsay, France.; Gazzah A; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Bahleda R; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Michot JM; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Danlos FX; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Seknazi L; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Goldschmidt V; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Hénon C; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Sakkal M; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Smolenschi C; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Champiat S; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Marabelle A; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Loriot Y; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Nagera Lazarovici C; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Ap-Thomas Z; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Beraud Chaullet G; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Ponce Aix S; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Massard C; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Ouali K; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.; Frelaut M; Department of Medical Oncology, Gustave Roussy, 94805, Villejuif, France.; Baldini C; Department of Therapeutic Innovation and Early Phase Trials, Gustave Roussy, 94805, Villejuif, France.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Massard, C. L.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어